Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (241-250 of 418) with videos related to

Pageof 42
Sort By:
Archives of Dermatology|April 10, 2002
Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gelSusan Bershad, Giselle Kranjac Singer, Janice E Parente, et al.
Journal of the American Academy of Dermatology|August 7, 2017
The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b studyJerry Bagel, Kristina Callis Duffin, Angela Moore, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Relapse, rebound, and psoriasis adverse events: an advisory group reportWayne Carey, Scott Glazer, Alice B Gottlieb, et al.
Journal of the American Academy of Dermatology|June 4, 2018
Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatmentMichael H Gold, Mark Lebwohl, Brian S Biesman, et al.
Journal of the American Academy of Dermatology|July 6, 2010
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendationsMark Lebwohl, Newman Yeilding, Philippe Szapary, et al.
Carcinogenesis|March 2, 2002
Effects of the isoflavone 4',5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamageEileen Q Shyong, Yuhun Lu, Alison Lazinsky, et al.
The Journal of Allergy and Clinical Immunology|July 15, 2023
Difelikefalin suppresses itch and reduces scratching independent of inflammation in a murine model of atopic dermatitisMasato Tamari, Lydia Zamidar, Aaron M Ver Heul, et al.
The Journal of Dermatological Treatment|May 11, 2016
Adherence to topical therapies in actinic keratosis: A literature reviewPeter Foley, Eggert Stockfleth, Ketty Peris, et al.
Journal of Drugs in Dermatology : JDD|February 5, 2013
Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trialAlan Menter, Linda Stein Gold, Michael Bukhalo, et al.
The Journal of Dermatological Treatment|October 7, 2020
Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trialsAlice B Gottlieb, Jashin J Wu, Christopher E M Griffiths, et al.
Pageof 42

Showing results (241-250 of 418) with videos related to

Sort By:
Pageof 42
Archives of Dermatology|April 10, 2002
Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gelSusan Bershad, Giselle Kranjac Singer, Janice E Parente, et al.
Journal of the American Academy of Dermatology|August 7, 2017
The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b studyJerry Bagel, Kristina Callis Duffin, Angela Moore, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Relapse, rebound, and psoriasis adverse events: an advisory group reportWayne Carey, Scott Glazer, Alice B Gottlieb, et al.
Journal of the American Academy of Dermatology|June 4, 2018
Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatmentMichael H Gold, Mark Lebwohl, Brian S Biesman, et al.
Journal of the American Academy of Dermatology|July 6, 2010
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendationsMark Lebwohl, Newman Yeilding, Philippe Szapary, et al.
Carcinogenesis|March 2, 2002
Effects of the isoflavone 4',5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamageEileen Q Shyong, Yuhun Lu, Alison Lazinsky, et al.
The Journal of Allergy and Clinical Immunology|July 15, 2023
Difelikefalin suppresses itch and reduces scratching independent of inflammation in a murine model of atopic dermatitisMasato Tamari, Lydia Zamidar, Aaron M Ver Heul, et al.
The Journal of Dermatological Treatment|May 11, 2016
Adherence to topical therapies in actinic keratosis: A literature reviewPeter Foley, Eggert Stockfleth, Ketty Peris, et al.
Journal of Drugs in Dermatology : JDD|February 5, 2013
Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trialAlan Menter, Linda Stein Gold, Michael Bukhalo, et al.
The Journal of Dermatological Treatment|October 7, 2020
Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trialsAlice B Gottlieb, Jashin J Wu, Christopher E M Griffiths, et al.
Pageof 42